[1. Altenburg J. et al.: Immunomodulatory effects of macrolide antibiotic- part 1: biological mechanisms. Respiration, 81, 67, 2011.10.1159/00032031920733281]Search in Google Scholar
[2. Cazalias J., Tanabe S., Gagnon G.: Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood. Inflammation, 32, 130, 2009.]Search in Google Scholar
[3. Culic O., Erakovic V., Parnham M.J.: Anti-inflammatory effects of macrolide antibiotics. Eur. J. Pharmacol., 429, 209, 2001.]Search in Google Scholar
[4. Friedlander A.L., Albert R.K.: Chronic macrolide therapy in inflammatory airway diseases. Chest, 138, 1202, 2010.]Search in Google Scholar
[5. Hodge S., Hodge G., Jersmann H.: Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 178, 139, 2008.]Search in Google Scholar
[6. Itkin I.H., Menzel M.L.: The use of macrolide antibiotic substances in the treatment of astma. J. Allergy, 45, 146, 1970.]Search in Google Scholar
[7. Kudoh S., Azuma A., Yamamoto M.: Improvement of survival in patients with diffuse panbrochiolitis treated with low-dose erythromycin.Am. J. Respir. Crit. Care Med., 157, 1829, 1998.]Search in Google Scholar
[8. Martinez F., Curtis J., Albert R.: Role of macrolide therapy in chronic obstructive pulmonary disease. Interantional Journal of COPD, 3, 331, 2008.]Search in Google Scholar
[9. Rubin B.K., Henke M.O.: Immunomodulatory activity and effectiveness of macrolides in chronic airway disease. Chest, 125, 70, 2004.]Search in Google Scholar
[10. Targowski T., Jahnz-Różyk K.: Immunomodulatory properties of macrolides. Pol. Merk. Lek., 149, 408, 2008.]Search in Google Scholar
[11. Ungureanu V.: Macrolides, lincosamides, streptogramines (MLS): mechanisms of action and resistance. Bacteriol Virusol Parazitol Epidemiol., 55, 131, 2010.]Search in Google Scholar
[12. Zarogoulidis P. et al.: Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practise in respiratory diseases. Eur. J. Clin. Pharmacol., 68, 479, 2012.10.1007/s00228-011-1161-x22105373]Search in Google Scholar
